JPRN-UMIN000022398Completed未知
Clinical study of favipiravir for patients with severe fever with thrombocytopenia syndrome - Clinical study of favipiravir for patients with severe fever with thrombocytopenia syndrome
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Ehime University Hospital
- Enrollment
- 25
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 16years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1. Patients who are revealed of SFTSV load decreasing or had improvements of clinical manifestation 2. Patients who had been running fever while seven or more days 3. Patients who are treated for severe hepatic disease(Child-Pugh grade C) 4. Pregnant women or patients who might be pregnant 5. Patients who have difficulty in taking the extremely effective contraception during the first day of treatment with favipiravir until 7days after the medication 6. Patients who suffer from hereditary xanthinuria 7. Patients who have hypouriceia(less than 1mg/dl) or had been made a diagnosis of urinary tract xanthine calculus 8. Patients who have a history of hyper sensitivity for favipiravir 9. Patients who are inadequate for enrollment for this protocol with the investigator's judgment
Investigators
Similar Trials
Completed
Not Applicable
Clinical study of favipiravir for patients with severe fever with thrombocytopenia syndrome 2017severe fever with thrombocytopenia syndromeJPRN-UMIN000029020Ehime University Hospital10
Completed
Phase 3
Favipiravir effectiveness in patients undergoing COVID19 Acute respiratory distress syndrome (ARDS)covid positive.Coronavirus infection, unspecifiedB34.2IRCT20150107020592N26Masih Daneshvari Hospital20
Recruiting
Phase 3
The therapeutic effect of Favipiravir in COVID-19 patientsIRCT20211004052664N1Shahid Beheshti University of Medical Sciences80
Completed
Phase 3
Phase III Clinical Study on Favipiravir in Patients with Severe Fever with Thrombocytopenia SyndromeSevere Fever with Thrombocytopenia Syndrome (SFTS)JPRN-jRCT2080223816FUJIFILM Toyama Chemical Co., Ltd. (Former Toyama Chemical Co., Ltd.)30
Active, not recruiting
Not Applicable
Clinical trial on use of Saquinavir in patients affected by primitive glomerulonephritis associated to resistant nephrotic syndrome. - NDEUCTR2009-013484-19-ITOSPEDALE POLICLINICO S. MATTEO